Furthermore, prior studies by the groups of Yamada, Kjellman, and Bayin showed that TGF-β protein and both receptors are abundantly expressed in malignant glial tumors and that TGF-β1 and -β2 mRNA expression correlated with tumor grade [19,20,21]. This evidence concerns the gene TGFB1 and neoplasm.